Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBioPharma Dive ↗
Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb …
The WeekBioPharma Dive ↗
Blair Jackson says the next 12 months may be the most important in Alkermes' history, as the brain drugmaker r…
The WeekPharmaVoice ↗
AI hasn't always been what it was cracked up to be in pharma. Here's where execs say the technology hasn't liv…
The WeekFiercePharma ↗
BeOne Medicines has extended its relationship with Blood Cancer United, committing $5 million over three years…
The WeekFierceBiotech ↗
Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery pl…
The WeekBriefing
Otsuka’s ADHD drug candidate met its Phase 3b endpoint in adults with comorbid anxiety, adding key data weeks …
The WeekDrug Channels ↗
Today's guest post comes from Geoffrey Chaiken and Matthew Chaiken, Co-founders of BlinkRx. Geoffrey and Matth…
The WeekDrug Channels ↗
Today's guest post comes from Geoffrey Chaiken and Matthew Chaiken, Co-founders of BlinkRx. Geoffrey and Matth…
The WeekSTAT News ↗
A report about unusual access to an experimental obesity drug has raised interest in the condition pulmonary h…
The WeekAJMC ↗
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple Negative Breast Cancer…
The WeekBioPharma Dive ↗
The transaction marks the latest turn in the fortunes of Passage Bio, one of the companies started by gene the…
The WeekPharmaVoice ↗
Experts are sounding the alarm about the rise in drug-resistant superbugs and urging more action.…
The WeekFiercePharma ↗
AstraZeneca has partnered with YMCA of the USA to increase awareness of cancer screening and early detection.…
The WeekFierceBiotech ↗
Passage Bio, the Philadelphia-based gene therapy outfit that launched a strategic review earlier this year aft…
The WeekBriefing
The FDA approved Trodelvy for first-line triple-negative breast cancer regardless of PD-L1 status, days after …
The WeekSTAT News ↗
It's an unusual time to be in the vaccine business. But in the view of those gathered at the BIO conference th…
The WeekAJMC ↗
Stigma and Delayed Diagnosis Are Driving Up Obstructive Sleep Apnea Costs…
The WeekBioPharma Dive ↗
The startup claims to have a "differentiated" antibody that can provide long-lasting protection against a vari…
The WeekPharmaVoice ↗
A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather th…
The WeekPharmaVoice ↗
Whether from layoffs or exits, Novo Nordisk, Genentech and Allogene saw changes to their executive teams over …
The WeekFiercePharma ↗
Julianne Hough is the new face of Revance's Botox rival Daxxify. The company has enlisted the dancer, actress …
The WeekFierceBiotech ↗
An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch …
The WeekBriefing
Serapha Bio forms via Boundless Bio reverse merger, backed by $230M to advance SERP-01, a China-derived base-e…
The WeekSTAT News ↗
"With the right structure, Americans will roll up their sleeves, do the science, and trust the result," Manous…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.